Oral opioid shortages to continue

Shortages of Oxynorm capsules and Ordine oral liquid are expected to last until late 2024, the TGA reports  Manufacturers of two oral opioid products are forecasting that shortages of some preparations could extend until late November and beyond.  In an update, the Therapeutic Goods Administration (TGA) reported that Mundipharma has reversed its decision to discontinue

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Credentials for consultants launch
Next Contaminated cocaine prompts Take Home Naloxone push